Skip to main content
Erschienen in: Pediatric Cardiology 6/2023

08.02.2023 | Original Article

Prediction Model with External Validation for Early Detection of Postoperative Pediatric Chylothorax

verfasst von: Rohin Moza, Melissa Winder, Gregory T. Adamson, Zhining Ou, Angela P. Presson, Senthuran Vijayarajah, Stephanie A. Goldstein, David K. Bailly

Erschienen in: Pediatric Cardiology | Ausgabe 6/2023

Einloggen, um Zugang zu erhalten

Abstract

Earlier diagnosis of chylothorax following pediatric cardiac surgery is associated with decreased duration of chylothorax. Pleural fluid testing is used to diagnosis chylothorax which may delay detection in patients who are not enterally fed at time of chylothorax onset. Our aim was to develop and externally validate a prediction model to detect chylothorax earlier than pleural fluid testing in pediatric patients following cardiac surgery. A multivariable logistic regression model was developed to detect chylothorax using a stepwise approach. The model was developed using data from patients < 18 years following cardiac surgery from Primary Children’s Hospital, a tertiary-care academic center, between 2017 and 2020. External validation used a contemporary cohort (n = 171) from Lucille Packard Children’s Hospital. A total of 763 encounters (735 patients) were analyzed, of which 72 had chylothorax. The final variables selected were chest tube output (CTO) the day after sternal closure (dichotomized at 15.6 mL/kg/day, and as a continuous variable) and delayed sternal closure. The highest odds of chylothorax were associated with CTO on post-sternal closure day 1 > 15.6 mL/kg/day (odds ratio 11.3, 95% CI 6,3, 21.3). The c-statistic for the internal and external validation datasets using the dichotomized CTO variable were 0.78 (95% CI 0.73, 0.82) and 0.84 (95% CI, 0.78, 0.9) and performance improved when using CTO as a continuous variable (OR 0.84, CI: 95% CI 0.80, 0.87). Using the models described, chylothorax after pediatric cardiac surgery may be detected earlier and without reliance on enteral feeds.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Winder MM, Eckhauser AW, Delgado-Corcoran C, Smout RJ, Marietta J, Bailly DK (2018) A protocol to decrease postoperative chylous effusion duration in children. Cardiol Young 28:816–825CrossRefPubMed Winder MM, Eckhauser AW, Delgado-Corcoran C, Smout RJ, Marietta J, Bailly DK (2018) A protocol to decrease postoperative chylous effusion duration in children. Cardiol Young 28:816–825CrossRefPubMed
2.
Zurück zum Zitat Bender B, Murthy V, Chamberlain RS (2016) The changing management of chylothorax in the modern era. Eur J Cardiothorac Surg 49:18–24CrossRefPubMed Bender B, Murthy V, Chamberlain RS (2016) The changing management of chylothorax in the modern era. Eur J Cardiothorac Surg 49:18–24CrossRefPubMed
3.
Zurück zum Zitat Yeh J, Brown ER, Kellogg KA, Donohue JE, Yu S, Gaies MG, Fifer CG, Hirsch JC, Aiyagari R (2013) Utility of a clinical practice guideline in treatment of chylothorax in the postoperative congenital heart patient. Ann Thorac Surg 96:930–936CrossRefPubMed Yeh J, Brown ER, Kellogg KA, Donohue JE, Yu S, Gaies MG, Fifer CG, Hirsch JC, Aiyagari R (2013) Utility of a clinical practice guideline in treatment of chylothorax in the postoperative congenital heart patient. Ann Thorac Surg 96:930–936CrossRefPubMed
4.
Zurück zum Zitat Marino LV, Bell KL, Woodgate J, British Dietetic Association Paediatric Cardiology Interest G and Doolan A (2019) An international survey of the nutrition management of chylothorax: a time for change. Cardiol Young 29:1127–1136CrossRefPubMed Marino LV, Bell KL, Woodgate J, British Dietetic Association Paediatric Cardiology Interest G and Doolan A (2019) An international survey of the nutrition management of chylothorax: a time for change. Cardiol Young 29:1127–1136CrossRefPubMed
5.
Zurück zum Zitat Chan EH, Russell JL, Williams WG, Van Arsdell GS, Coles JG, McCrindle BW (2005) Postoperative chylothorax after cardiothoracic surgery in children. Ann Thorac Surg 80:1864–1870CrossRefPubMed Chan EH, Russell JL, Williams WG, Van Arsdell GS, Coles JG, McCrindle BW (2005) Postoperative chylothorax after cardiothoracic surgery in children. Ann Thorac Surg 80:1864–1870CrossRefPubMed
6.
Zurück zum Zitat Costa KM, Saxena AK (2018) Surgical chylothorax in neonates: management and outcomes. World J Pediatr 14:110–115CrossRefPubMed Costa KM, Saxena AK (2018) Surgical chylothorax in neonates: management and outcomes. World J Pediatr 14:110–115CrossRefPubMed
7.
Zurück zum Zitat McGrath EE, Blades Z, Anderson PB (2010) Chylothorax: aetiology, diagnosis and therapeutic options. Respir Med 104:1–8CrossRefPubMed McGrath EE, Blades Z, Anderson PB (2010) Chylothorax: aetiology, diagnosis and therapeutic options. Respir Med 104:1–8CrossRefPubMed
8.
Zurück zum Zitat Hermon M, Tenner E, Burda G, Strohmaier W, Schlager G, Golej J (2019) Chylothorax and chylous-like diseases in children: clinical management. Front Pediatr 7:258CrossRefPubMedPubMedCentral Hermon M, Tenner E, Burda G, Strohmaier W, Schlager G, Golej J (2019) Chylothorax and chylous-like diseases in children: clinical management. Front Pediatr 7:258CrossRefPubMedPubMedCentral
9.
Zurück zum Zitat Doell C, Bernet V, Molinari L, Beck I, Balmer C, Latal B (2011) Children with genetic disorders undergoing open-heart surgery: are they at increased risk for postoperative complications? Pediatr Crit Care Med 12:539–544CrossRefPubMed Doell C, Bernet V, Molinari L, Beck I, Balmer C, Latal B (2011) Children with genetic disorders undergoing open-heart surgery: are they at increased risk for postoperative complications? Pediatr Crit Care Med 12:539–544CrossRefPubMed
10.
Zurück zum Zitat Waterhouse SG, Vergales JE, Conaway MR, Lee L (2018) Predictive factors for central line-associated bloodstream infections in pediatric cardiac surgery patients with chylothorax. Pediatr Crit Care Med 19:810–815CrossRefPubMed Waterhouse SG, Vergales JE, Conaway MR, Lee L (2018) Predictive factors for central line-associated bloodstream infections in pediatric cardiac surgery patients with chylothorax. Pediatr Crit Care Med 19:810–815CrossRefPubMed
11.
Zurück zum Zitat Kahraman D, Keskin G, Khalil E, Dogan OF (2020) Ten-year clinical experience on chylothorax after cardiovascular surgery. Heart Surg Forum 23:E081–E087CrossRefPubMed Kahraman D, Keskin G, Khalil E, Dogan OF (2020) Ten-year clinical experience on chylothorax after cardiovascular surgery. Heart Surg Forum 23:E081–E087CrossRefPubMed
12.
Zurück zum Zitat Buckley JR, Graham EM, Gaies M, Alten JA, Cooper DS, Costello JM, Domnina Y, Klugman D, Pasquali SK, Donohue JE, Zhang W, Scheurer MA (2017) Clinical epidemiology and centre variation in chylothorax rates after cardiac surgery in children: a report from the Pediatric Cardiac Critical Care Consortium. Cardiol Young. 27:1678–1685CrossRef Buckley JR, Graham EM, Gaies M, Alten JA, Cooper DS, Costello JM, Domnina Y, Klugman D, Pasquali SK, Donohue JE, Zhang W, Scheurer MA (2017) Clinical epidemiology and centre variation in chylothorax rates after cardiac surgery in children: a report from the Pediatric Cardiac Critical Care Consortium. Cardiol Young. 27:1678–1685CrossRef
13.
Zurück zum Zitat Schild HH, Strassburg CP, Welz A, Kalff J (2013) Treatment options in patients with chylothorax. Dtsch Arztebl Int 110:819–826PubMedPubMedCentral Schild HH, Strassburg CP, Welz A, Kalff J (2013) Treatment options in patients with chylothorax. Dtsch Arztebl Int 110:819–826PubMedPubMedCentral
14.
Zurück zum Zitat Soto-Martinez M, Massie J (2009) Chylothorax: diagnosis and management in children. Paediatr Respir Rev 10:199–207CrossRefPubMed Soto-Martinez M, Massie J (2009) Chylothorax: diagnosis and management in children. Paediatr Respir Rev 10:199–207CrossRefPubMed
15.
Zurück zum Zitat Huggins JT (2010) Chylothorax and cholesterol pleural effusion. Semin Respir Crit Care Med 31:743–750CrossRefPubMed Huggins JT (2010) Chylothorax and cholesterol pleural effusion. Semin Respir Crit Care Med 31:743–750CrossRefPubMed
16.
Zurück zum Zitat Staats BA, Ellefson RD, Budahn LL, Dines DE, Prakash UB, Offord K (1980) The lipoprotein profile of chylous and nonchylous pleural effusions. Mayo Clin Proc 55:700–704PubMed Staats BA, Ellefson RD, Budahn LL, Dines DE, Prakash UB, Offord K (1980) The lipoprotein profile of chylous and nonchylous pleural effusions. Mayo Clin Proc 55:700–704PubMed
17.
Zurück zum Zitat Büttiker V, Fanconi S, Burger R (1999) Chylothorax in children: guidelines for diagnosis and management. Chest 116:682–687CrossRefPubMed Büttiker V, Fanconi S, Burger R (1999) Chylothorax in children: guidelines for diagnosis and management. Chest 116:682–687CrossRefPubMed
18.
Zurück zum Zitat Agrawal V, Doelken P, Sahn SA (2008) Pleural fluid analysis in chylous pleural effusion. Chest 133:1436–1441CrossRefPubMed Agrawal V, Doelken P, Sahn SA (2008) Pleural fluid analysis in chylous pleural effusion. Chest 133:1436–1441CrossRefPubMed
19.
Zurück zum Zitat Moons KG, Altman DG, Reitsma JB, Ioannidis JP, Macaskill P, Steyerberg EW, Vickers AJ, Ransohoff DF, Collins GS (2015) Transparent Reporting of a multivariable prediction model for Individual Prognosis or Diagnosis (TRIPOD): explanation and elaboration. Ann Intern Med 162:W1-73CrossRefPubMed Moons KG, Altman DG, Reitsma JB, Ioannidis JP, Macaskill P, Steyerberg EW, Vickers AJ, Ransohoff DF, Collins GS (2015) Transparent Reporting of a multivariable prediction model for Individual Prognosis or Diagnosis (TRIPOD): explanation and elaboration. Ann Intern Med 162:W1-73CrossRefPubMed
20.
Zurück zum Zitat O’Brien SM, Clarke DR, Jacobs JP, Jacobs ML, Lacour-Gayet FG, Pizarro C, Welke KF, Maruszewski B, Tobota Z, Miller WJ, Hamilton L, Peterson ED, Mavroudis C, Edwards FH (2009) An empirically based tool for analyzing mortality associated with congenital heart surgery. J Thorac Cardiovasc Surg 138:1139–1153CrossRefPubMed O’Brien SM, Clarke DR, Jacobs JP, Jacobs ML, Lacour-Gayet FG, Pizarro C, Welke KF, Maruszewski B, Tobota Z, Miller WJ, Hamilton L, Peterson ED, Mavroudis C, Edwards FH (2009) An empirically based tool for analyzing mortality associated with congenital heart surgery. J Thorac Cardiovasc Surg 138:1139–1153CrossRefPubMed
21.
Zurück zum Zitat Loomba RS, Wong J, Davis M, Kane S, Heenan B, Farias JS, Villarreal EG, Flores S (2021) Medical interventions for chylothorax and their impacts on need for surgical intervention and admission characteristics: a multicenter retrospective insight. Pediatr Cardiol 42:543–553CrossRefPubMed Loomba RS, Wong J, Davis M, Kane S, Heenan B, Farias JS, Villarreal EG, Flores S (2021) Medical interventions for chylothorax and their impacts on need for surgical intervention and admission characteristics: a multicenter retrospective insight. Pediatr Cardiol 42:543–553CrossRefPubMed
22.
Zurück zum Zitat Panthongviriyakul C, Bines JE (2008) Post-operative chylothorax in children: an evidence-based management algorithm. J Paediatr Child Health 44:716–721CrossRefPubMed Panthongviriyakul C, Bines JE (2008) Post-operative chylothorax in children: an evidence-based management algorithm. J Paediatr Child Health 44:716–721CrossRefPubMed
23.
Zurück zum Zitat Biewer ES, Zürn C, Arnold R, Glöckler M, Schulte-Mönting J, Schlensak C, Dittrich S (2010) Chylothorax after surgery on congenital heart disease in newborns and infants-risk factors and efficacy of MCT-diet. J Cardiothorac Surg 5:127CrossRefPubMedPubMedCentral Biewer ES, Zürn C, Arnold R, Glöckler M, Schulte-Mönting J, Schlensak C, Dittrich S (2010) Chylothorax after surgery on congenital heart disease in newborns and infants-risk factors and efficacy of MCT-diet. J Cardiothorac Surg 5:127CrossRefPubMedPubMedCentral
24.
Zurück zum Zitat Day TG, Zannino D, Golshevsky D, d’Udekem Y, Brizard C, Cheung MMH (2018) Chylothorax following paediatric cardiac surgery: a case-control study. Cardiol Young 28:222–228CrossRefPubMed Day TG, Zannino D, Golshevsky D, d’Udekem Y, Brizard C, Cheung MMH (2018) Chylothorax following paediatric cardiac surgery: a case-control study. Cardiol Young 28:222–228CrossRefPubMed
26.
Zurück zum Zitat Hanley JA, McNeil BJ (1982) The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology 143:29–36CrossRefPubMed Hanley JA, McNeil BJ (1982) The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology 143:29–36CrossRefPubMed
27.
Zurück zum Zitat Esther CR Jr, Barker PM (2004) Pulmonary lymphangiectasia: diagnosis and clinical course. Pediatr Pulmonol 38:308–313CrossRefPubMed Esther CR Jr, Barker PM (2004) Pulmonary lymphangiectasia: diagnosis and clinical course. Pediatr Pulmonol 38:308–313CrossRefPubMed
28.
Zurück zum Zitat Mery CM, Moffett BS, Khan MS, Zhang W, Guzman-Pruneda FA, Fraser CD Jr, Cabrera AG (2014) Incidence and treatment of chylothorax after cardiac surgery in children: analysis of a large multi-institution database. J Thorac Cardiovasc Surg. 147:678–86 (discussion 685-6)CrossRefPubMed Mery CM, Moffett BS, Khan MS, Zhang W, Guzman-Pruneda FA, Fraser CD Jr, Cabrera AG (2014) Incidence and treatment of chylothorax after cardiac surgery in children: analysis of a large multi-institution database. J Thorac Cardiovasc Surg. 147:678–86 (discussion 685-6)CrossRefPubMed
29.
Zurück zum Zitat Savla JJ, Itkin M, Rossano JW, Dori Y (2017) Post-operative chylothorax in patients with congenital heart disease. J Am Coll Cardiol 69:2410–2422CrossRefPubMed Savla JJ, Itkin M, Rossano JW, Dori Y (2017) Post-operative chylothorax in patients with congenital heart disease. J Am Coll Cardiol 69:2410–2422CrossRefPubMed
30.
Zurück zum Zitat Justice L, Buckley JR, Floh A, Horsley M, Alten J, Anand V, Schwartz SM (2018) Nutrition considerations in the pediatric cardiac intensive care unit patient. World J Pediatr Congenit Heart Surg 9:333–343CrossRefPubMed Justice L, Buckley JR, Floh A, Horsley M, Alten J, Anand V, Schwartz SM (2018) Nutrition considerations in the pediatric cardiac intensive care unit patient. World J Pediatr Congenit Heart Surg 9:333–343CrossRefPubMed
31.
Zurück zum Zitat DiLauro S, Russell J, McCrindle BW, Tomlinson C, Unger S, O’Connor DL (2020) Growth of cardiac infants with post-surgical chylothorax can be supported using modified fat breast milk with proactive nutrient-enrichment and advancement feeding protocols; an open-label trial. Clin Nutr ESPEN 38:19–27CrossRefPubMed DiLauro S, Russell J, McCrindle BW, Tomlinson C, Unger S, O’Connor DL (2020) Growth of cardiac infants with post-surgical chylothorax can be supported using modified fat breast milk with proactive nutrient-enrichment and advancement feeding protocols; an open-label trial. Clin Nutr ESPEN 38:19–27CrossRefPubMed
32.
Zurück zum Zitat Shin YR, Lee H, Park YH, Park HK (2020) Chylothorax after surgery for congenital cardiac disease: a prevention and management protocol. Korean J Thorac Cardiovasc Surg 53:41–48CrossRefPubMedPubMedCentral Shin YR, Lee H, Park YH, Park HK (2020) Chylothorax after surgery for congenital cardiac disease: a prevention and management protocol. Korean J Thorac Cardiovasc Surg 53:41–48CrossRefPubMedPubMedCentral
33.
Zurück zum Zitat Lo Rito M, Al-Radi OO, Saedi A, Kotani Y, Ben Sivarajan V, Russell JL, Caldarone CA, Van Arsdell GS, Honjo O (2018) Chylothorax and pleural effusion in contemporary extracardiac fenestrated fontan completion. J Thorac Cardiovasc Surg 155:2069–2077CrossRefPubMed Lo Rito M, Al-Radi OO, Saedi A, Kotani Y, Ben Sivarajan V, Russell JL, Caldarone CA, Van Arsdell GS, Honjo O (2018) Chylothorax and pleural effusion in contemporary extracardiac fenestrated fontan completion. J Thorac Cardiovasc Surg 155:2069–2077CrossRefPubMed
Metadaten
Titel
Prediction Model with External Validation for Early Detection of Postoperative Pediatric Chylothorax
verfasst von
Rohin Moza
Melissa Winder
Gregory T. Adamson
Zhining Ou
Angela P. Presson
Senthuran Vijayarajah
Stephanie A. Goldstein
David K. Bailly
Publikationsdatum
08.02.2023
Verlag
Springer US
Erschienen in
Pediatric Cardiology / Ausgabe 6/2023
Print ISSN: 0172-0643
Elektronische ISSN: 1432-1971
DOI
https://doi.org/10.1007/s00246-022-03034-4

Weitere Artikel der Ausgabe 6/2023

Pediatric Cardiology 6/2023 Zur Ausgabe

Nach Herzinfarkt mit Typ-1-Diabetes schlechtere Karten als mit Typ 2?

29.05.2024 Herzinfarkt Nachrichten

Bei Menschen mit Typ-2-Diabetes sind die Chancen, einen Myokardinfarkt zu überleben, in den letzten 15 Jahren deutlich gestiegen – nicht jedoch bei Betroffenen mit Typ 1.

Erhöhtes Risiko fürs Herz unter Checkpointhemmer-Therapie

28.05.2024 Nebenwirkungen der Krebstherapie Nachrichten

Kardiotoxische Nebenwirkungen einer Therapie mit Immuncheckpointhemmern mögen selten sein – wenn sie aber auftreten, wird es für Patienten oft lebensgefährlich. Voruntersuchung und Monitoring sind daher obligat.

GLP-1-Agonisten können Fortschreiten diabetischer Retinopathie begünstigen

24.05.2024 Diabetische Retinopathie Nachrichten

Möglicherweise hängt es von der Art der Diabetesmedikamente ab, wie hoch das Risiko der Betroffenen ist, dass sich sehkraftgefährdende Komplikationen verschlimmern.

TAVI versus Klappenchirurgie: Neue Vergleichsstudie sorgt für Erstaunen

21.05.2024 TAVI Nachrichten

Bei schwerer Aortenstenose und obstruktiver KHK empfehlen die Leitlinien derzeit eine chirurgische Kombi-Behandlung aus Klappenersatz plus Bypass-OP. Diese Empfehlung wird allerdings jetzt durch eine aktuelle Studie infrage gestellt – mit überraschender Deutlichkeit.

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.